Stock Markets February 15, 2026 08:26 PM

Qube Shares Surge After Macquarie-Led Consortium Reaches A$11.7 Billion Buyout Agreement

Deal lifts logistics group to intraday record as UniSuper shifts its 15.07% stake into the consortium; dividend allowance to reduce per-share price

By Derek Hwang

Qube Holdings has accepted a A$11.7 billion takeover proposal from a consortium led by Macquarie Asset Management. The announcement pushed Qube shares to an intraday record before they remained below the consortium's A$5.20 per-share offer. The agreement allows Qube to pay dividends up to 40 Australian cents, which would be deducted from the offer price, and includes the transfer of UniSuper's 15.07% stake into the acquiring group.

Qube Shares Surge After Macquarie-Led Consortium Reaches A$11.7 Billion Buyout Agreement

Key Points

  • Qube agreed to be acquired for A$11.7 billion by a consortium led by Macquarie Asset Management.
  • Qube shares rose as much as 4.1% to a record intraday A$5.05 but remained below the A$5.20 per-share offer.
  • UniSuper will transfer its 15.07% stake into the consortium; Qube may pay dividends up to 40 Australian cents that will reduce the offer price accordingly.

Qube Holdings has reached a deal to be acquired by a consortium led by Macquarie Asset Management for A$11.7 billion (approximately $8.26 billion). The proposed transaction was disclosed publicly on Monday and prompted a notable market reaction for the Sydney-based logistics operator.

Shares in Qube rose in early trading, climbing as much as 4.1% to an intraday high of A$5.05. That level marked a record for the stock but remained under the consortium's stated purchase price of A$5.20 per share.

The firms said the arrangement follows months of discussions. Negotiations began in November when the Macquarie-led group submitted a non-binding proposal for Qube, which is described as Australia’s largest integrated provider of import and export logistics. The latest agreement formalizes the terms after that earlier approach.

Under the terms outlined by both parties, Qube will have the ability to pay dividends of up to 40 Australian cents prior to completion. Any dividend paid within that allowance will be subtracted from the A$5.20 offer price on a per-share basis, in line with the mechanism specified by the consortium and Qube.

Separately, Australian pension fund UniSuper, which holds a stated 15.07% stake in Qube, will deposit its shares into the consortium as part of the transaction structure. That transfer of UniSuper’s holding is included in the deal as presented.

The announcement attracted buying interest in the stock during the morning session, lifting the share price to new highs though below the consortium’s offer point. The companies provided the terms and the stakeholder transfer details as part of their joint release.


Context limitations: The companies provided the price, dividend allowance and UniSuper stake figures as part of the agreement. No additional details on timing, other consortium members, financing arrangements or regulatory steps were included in the announcement provided.

Risks

  • The agreement description does not include timing or regulatory approval details, leaving the completion timeline uncertain - this affects markets and the logistics sector.
  • Any dividend paid up to the allowed 40 Australian cents will lower the effective takeover price for remaining shareholders - this impacts equity holders and pension fund positions.
  • The announcement lacks detail on financing or other consortium partners beyond Macquarie Asset Management, creating uncertainty around deal execution and financing - relevant to transaction and capital markets.

More from Stock Markets

Red Cat Holdings Sees After-Hours Slide Following $200 Million Equity Offering Announcement May 12, 2026 FCC Signs Off on EchoStar’s $40 Billion Spectrum Sale to SpaceX and AT&T May 12, 2026 CFPB Leadership Moving to Bring Staff Back to Office After Year-Long Closure May 12, 2026 AEP to Sell $2.6 Billion in Stock; Shares Slip After-Hours May 12, 2026 Mirum Pharmaceuticals Announces $600M Convertible Bond Sale; Shares Slip in After-Hours Trading May 12, 2026